Facial Hair Removal Breakthrough – The Story
With approximately 50 million women in the USA alone concerned about facial hair removal according to some estimates, it is no wonder that some of the major health and personal care companies invested much time and research into the development of a response.
The answer came on 31 Developed in July 2000 with Bristol-Myer Squibb and The Gillette Company, together with the introduction of Vaniqa, a cream to slow down and announced to minimize facial hair growth.
As a result of the application of Vaniqa cream, millions of womennow had the opportunity to facial hair removal much easier.
Sugar yes, she still continued with its regular method of facial hair removal, be it waxing, plucking or threading, but do so in connection with the use Vaniqa reqularly made it much easier and facial hair removal sessions and more rare.
The road to FDA (Food and Drug Administration) approval for any drug is a lengthy process that takes years. This is of course to the publicProvide protection as secure as possible, there are no serious adverse effects.
Bristol-Myer Squibb and Gillette succeeded FDA approved Vaniqa, it is as a prescription cream from a doctor available.
The background to the introduction of Vaniqa is intriguing:
A drug called eflornithine was developed many years ago to combat malignant cancer. Unfortunately it was not effective for this purpose.
But by chance, it wasEflornithine discovered that against the general condition as sleeping sickness, which is known in many parts of Africa, was effective.
A curious side effect of the drug was hair loss, as it entered the case with some drugs in the fight against cancer.
Other studies have shown that eflornithine the work of an enzyme linked to hair growth inhibition. This led to the production of a cream containing 139mg / g of eflornithine hydrochloride. He took the name "eflornithineHydrochloride 13.9% and was sold under the brand name – Vaniqa.
Vaniqa is a topical cream that support directly to the skin with facial hair removal, especially in the areas around the lips and under the chin.
Over time, both Bristol-Myer Squibb and The Gillette Company believes that Vaniqa is no longer consistent with their future objectives and targets, so they sold it in June 2002 to a company called Women First HealthCare.
In June 2004 the U.S. Bankruptcy Courtannounced that SkinMedica, a pharmaceutical company specializing in dermatology, had won the bid for all U.S. rights and some international rights for Vaniqa from Women First Healthcare.
As of this writing, Vaniqa continues to be sold under prescription in the USA. It is also available in the European Union from Shire Pharmaceuticals who hold a sub-license for exclusive rights to market it in the EU and some other areas.
Evidently there is a future for this product, given the Interest in the acquisition of rights to produce and sell, paid for with support from more than thirty six million U.S. dollars from SkinMedica to Women First HealthCare.
Thus Vaniqa for all?
Not quite. It is for women without men, and girls under the age of 12 is recommended not to use it. In clinical tests, approximately 58% of the women she made a difference to the rate of facial hair growth. It seemed to have better results with women after the menopause.
This means that a fairPercentage has not notice any difference.
As with any drug it can cause side effects, although, in the case of Vaniqa, these minimal and relate mainly to skin irritation and rash for a small number of users.
So to clarify, Vaniqa is not a depilatory facial image. It is more of a facial hair growth inhibitor. Apply it regularly every day to a reduction in hair growth for at least half of the women who do use it as a result, their preferred method of facial hairRemoval of waxes, pull, or tapping, much easier.
For the answers to how to use Vaniqa For best results, check the resource page listed.